Genetic Signatures Limited (GSS.AX)

AUD 0.38

(-7.41%)

Total Liabilities Summary of Genetic Signatures Limited

Genetic Signatures Limited's latest annual total liabilities in 2024 was 6.18 Million AUD , up 0.32% from previous year.
Genetic Signatures Limited's latest quarterly total liabilities in 2024 FY was 6.18 Million AUD , up 0.32% from previous quarter.
Genetic Signatures Limited reported annual total liabilities of 6.16 Million AUD in 2023, up 27.04% from previous year.
Genetic Signatures Limited reported annual total liabilities of 4.85 Million AUD in 2022, up 3.08% from previous year.
Genetic Signatures Limited reported quarterly total liabilities of 6.18 Million AUD for 2024 FY, up 0.32% from previous quarter.
Genetic Signatures Limited reported quarterly total liabilities of 6.18 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual Total Liabilities of Genetic Signatures Limited (2024 - 2013)

Year	Total Liabilities	Total Liabilities Growth
2024	6.18 Million AUD	0.32%
2023	6.16 Million AUD	27.04%
2022	4.85 Million AUD	3.08%
2021	4.7 Million AUD	24.33%
2020	3.78 Million AUD	142.54%
2019	1.56 Million AUD	29.07%
2018	1.2 Million AUD	1.65%
2017	1.18 Million AUD	-7.3%
2016	1.28 Million AUD	72.71%
2015	743.14 Thousand AUD	100.59%
2014	370.47 Thousand AUD	-91.24%
2013	4.23 Million AUD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.95 Million AUD	0.0%
2024 FY	6.18 Million AUD	0.32%
2024 Q4	6.18 Million AUD	0.0%
2023 Q2	4.47 Million AUD	0.0%
2023 Q4	6.16 Million AUD	0.0%
2023 FY	6.16 Million AUD	27.04%
2022 FY	4.85 Million AUD	3.08%
2022 Q4	4.85 Million AUD	0.0%
2022 Q2	3.92 Million AUD	0.0%
2021 FY	4.7 Million AUD	24.33%
2021 Q4	4.7 Million AUD	0.0%
2021 Q2	6.01 Million AUD	0.0%
2020 Q2	2.37 Million AUD	0.0%
2020 Q4	3.78 Million AUD	0.0%
2020 FY	3.78 Million AUD	142.54%
2019 FY	1.56 Million AUD	29.07%
2019 Q2	1.36 Million AUD	0.0%
2019 Q4	1.56 Million AUD	0.0%
2018 FY	1.2 Million AUD	1.65%
2018 Q2	1.15 Million AUD	0.0%
2018 Q4	1.2 Million AUD	0.0%
2017 Q4	1.18 Million AUD	0.0%
2017 Q2	1.4 Million AUD	0.0%
2017 FY	1.18 Million AUD	-7.3%
2016 Q4	1.28 Million AUD	0.0%
2016 FY	1.28 Million AUD	72.71%
2016 Q2	835.53 Thousand AUD	0.0%
2015 Q4	737.78 Thousand AUD	0.0%
2015 Q3	737.78 Thousand AUD	0.0%
2015 FY	743.14 Thousand AUD	100.59%
2015 Q1	- AUD	0.0%
2014 FY	370.47 Thousand AUD	-91.24%
2013 FY	4.23 Million AUD	0.0%

Peer Total Liabilities Comparison of Genetic Signatures Limited

Name	Total Liabilities	Total Liabilities Difference
Australian Clinical Labs Limited	415.29 Million AUD	98.511%
BCAL Diagnostics Limited	3.67 Million AUD	-68.172%
Genetic Technologies Limited	4.35 Million AUD	-41.962%
Healius Limited	1.94 Billion AUD	99.682%
Imagion Biosystems Limited	8.37 Million AUD	26.155%
Integral Diagnostics Limited	442.56 Million AUD	98.603%
INOVIQ Ltd	1.71 Million AUD	-259.666%
Microba Life Sciences Limited	16.82 Million AUD	63.244%
Monash IVF Group Limited	261.81 Million AUD	97.638%
Rhythm Biosciences Limited	651.54 Thousand AUD	-849.133%
Sonic Healthcare Limited	6.75 Billion AUD	99.908%